Arctos NorthStar Acquisition Corp. (ANAC) NEW YORK STOCK EXCHANGE INC.
$9.77 -0.01 (-0.05%)
Market Cap: $308.98M
As of 05/19/22 04:00 PM EDT. Market closed.
Arctos NorthStar Acquisition Corp. (ANAC) NEW YORK STOCK EXCHANGE INC.
$9.77 -0.01 (-0.05%)
Market Cap: $308.98M
As of 05/19/22 04:00 PM EDT. Market closed.
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART
From:
To:
KEY STATS
Open
$0
Previous Close
$9.78
Days Range
$9.76 - $9.77
52 week range
$9.62 - $9.95
Volume
1
Avg. Volume (30 days)
170,640
Market Cap
$308.98M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
31,625,000
Open
$0
Previous Close
$9.78
Days Range
$9.76 - $9.77
52 week range
$9.62 - $9.95
Volume
1
Avg. Volume (30 days)
170,640
Market Cap
$308.98M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
31,625,000
Open in:
Open in:
INSIDER TRANSACTIONS FOR ARCTOS NORTHSTAR ACQUISITION CORP
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Hove Anders D | Director | Jun 24, 2016 | Option Exercise | $99.25 | 33,886 | 3,363,186 | 0 | Jun 24, 2016, 03:36 PM |
| Shapiro Lucy | Director | Jun 24, 2016 | Option Exercise | $99.25 | 794 | 78,805 | 0 | Jun 24, 2016, 03:04 PM |
| RIEFLIN WILLIAM JL | Director | Jun 24, 2016 | Option Exercise | $99.25 | 853 | 84,660 | 0 | Jun 24, 2016, 02:59 PM |
| RIEFLIN WILLIAM JL | Director | Jun 24, 2016 | Option Exercise | $99.25 | 89,000 | 8,833,250 | 0 | Jun 24, 2016, 02:59 PM |
| LESCHLY MARK | Director | Jun 24, 2016 | Option Exercise | $99.25 | 794 | 78,805 | 0 | Jun 24, 2016, 02:58 PM |
| Leonard Keith R | Director | Jun 24, 2016 | Option Exercise | $99.25 | 794 | 78,805 | 0 | Jun 24, 2016, 02:56 PM |
| WIERENGA WENDALL | Director | Jun 24, 2016 | Option Exercise | $99.25 | 794 | 78,805 | 0 | Jun 24, 2016, 02:55 PM |
| Zane Lee | SVP and Chief Medical Officer | Jun 24, 2016 | Option Exercise | $99.25 | 44,194 | 4,386,255 | 0 | Jun 24, 2016, 02:49 PM |
| Bell Graeme | Executive VP and CFO | Jun 24, 2016 | Option Exercise | $99.25 | 10,488 | 1,040,934 | 0 | Jun 24, 2016, 02:44 PM |
| BERNS PAUL L | President and CEO | Jun 24, 2016 | Option Exercise | $99.25 | 231,311 | 22,957,617 | 0 | Jun 24, 2016, 02:43 PM |
| Sullivan Ryan T | EVP and General Counsel | Jun 24, 2016 | Option Exercise | $99.25 | 30,132 | 2,990,601 | 0 | Jun 24, 2016, 02:41 PM |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | Jun 24, 2016 | Option Exercise | $99.25 | 68,985 | 6,846,761 | 0 | Jun 24, 2016, 02:32 PM |
| Bell Graeme | Executive VP and CFO | Jun 01, 2016 | Sale | $99.28 | 751 | 74,559 | 10,255 | Jun 03, 2016, 09:00 PM |
| Leonard Keith R | Director | May 23, 2016 | Option Exercise | $14.22 | 9,000 | 127,980 | 9,794 | May 24, 2016, 09:04 PM |
| Leonard Keith R | Director | May 23, 2016 | Sale | $99.70 | 9,000 | 897,300 | 794 | May 24, 2016, 09:04 PM |
| Hove Anders D | Director | May 16, 2016 | Sale | $99.59 | 353,881 | 35,241,707 | 272,250 | May 18, 2016, 05:44 PM |
| Sullivan Ryan T | EVP and General Counsel | Apr 29, 2016 | Sale | $66.33 | 3,125 | 207,281 | 30,132 | Apr 29, 2016, 09:00 PM |
| Hove Anders D | Director | Apr 14, 2016 | Option Exercise | $31.05 | 257,647 | 7,999,939 | 353,881 | Apr 15, 2016, 09:14 PM |
| Hove Anders D | Director | Apr 08, 2016 | Sale | $70.18 | 4,268 | 299,513 | 96,634 | Apr 11, 2016, 04:33 PM |
| Hove Anders D | Director | Apr 07, 2016 | Sale | $71.12 | 225,033 | 16,004,432 | 222,775 | Apr 11, 2016, 04:33 PM |
| RIEFLIN WILLIAM JL | Director | Mar 31, 2016 | Option Exercise | $8.33 | 89,000 | 741,080 | 89,000 | Apr 04, 2016, 08:00 PM |
| BERNS PAUL L | President and CEO | Mar 22, 2016 | Sale | $60.31 | 37,500 | 2,261,616 | 258,111 | Mar 22, 2016, 09:00 PM |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | Mar 02, 2016 | Sale | $63.86 | 9,000 | 574,753 | 75,385 | Mar 04, 2016, 09:00 PM |
| Zane Lee | SVP and Chief Medical Officer | Jan 22, 2016 | Option Exercise | $7.55 | 11,800 | 89,090 | 39,081 | Jan 25, 2016, 09:01 PM |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | Jan 19, 2016 | Option Exercise | $19.96 | 20,000 | 399,200 | 90,985 | Jan 21, 2016, 09:00 PM |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | Jan 19, 2016 | Sale | $95.41 | 20,000 | 1,908,204 | 89,785 | Jan 21, 2016, 09:00 PM |
| Zane Lee | SVP and Chief Medical Officer | Jan 15, 2016 | Sale | $89.57 | 1,466 | 131,310 | 27,281 | Jan 19, 2016, 09:00 PM |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | Jan 04, 2016 | Sale | $112.28 | 855 | 96,002 | 71,740 | Jan 05, 2016, 09:33 PM |
| Sullivan Ryan T | Sr. VP and General Counsel | Jan 04, 2016 | Sale | $111.78 | 733 | 81,935 | 27,540 | Jan 05, 2016, 09:31 PM |
| BERNS PAUL L | President and CEO | Jan 04, 2016 | Sale | $112.35 | 2,533 | 284,581 | 254,680 | Jan 05, 2016, 09:30 PM |
| Zane Lee | SVP and Chief Medical Officer | Dec 15, 2015 | Option Exercise | $5.59 | 14,000 | 78,260 | 42,747 | Dec 17, 2015, 09:01 PM |
| Zane Lee | SVP and Chief Medical Officer | Dec 15, 2015 | Sale | $113.17 | 14,000 | 1,584,350 | 41,173 | Dec 17, 2015, 09:01 PM |
| Hove Anders D | Director | Dec 15, 2015 | Sale | $111.25 | 900,000 | 100,125,000 | 325,535 | Dec 17, 2015, 05:13 PM |
| BERNS PAUL L | President and CEO | Dec 11, 2015 | Option Exercise | $10.00 | 20,000 | 200,060 | 274,760 | Dec 15, 2015, 09:00 PM |
| BERNS PAUL L | President and CEO | Dec 11, 2015 | Sale | $117.26 | 20,000 | 2,345,245 | 274,170 | Dec 15, 2015, 09:00 PM |
| Hove Anders D | Director | Dec 11, 2015 | Sale | $117.36 | 40,000 | 4,694,400 | 33,886 | Dec 15, 2015, 05:09 PM |
| Sullivan Ryan T | Sr. VP and General Counsel | Dec 10, 2015 | Option Exercise | $15.30 | 10,000 | 153,000 | 37,740 | Dec 11, 2015, 07:02 PM |
| Sullivan Ryan T | Sr. VP and General Counsel | Dec 10, 2015 | Sale | $110.41 | 10,000 | 1,104,108 | 36,640 | Dec 11, 2015, 07:02 PM |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | Dec 09, 2015 | Option Exercise | $19.96 | 20,000 | 399,200 | 91,840 | Dec 11, 2015, 07:00 PM |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | Dec 09, 2015 | Sale | $107.90 | 20,000 | 2,158,097 | 74,570 | Dec 11, 2015, 07:00 PM |
| Hove Anders D | Director | Nov 10, 2015 | Sale | $103.60 | 100,295 | 10,390,562 | 1,598,517 | Nov 12, 2015, 04:59 PM |
| BERNS PAUL L | President and CEO | Sep 15, 2015 | Option Exercise | $5.18 | 20,000 | 103,640 | 274,760 | Sep 17, 2015, 09:46 PM |
| BERNS PAUL L | President and CEO | Sep 15, 2015 | Sale | $139.83 | 20,000 | 2,796,525 | 272,768 | Sep 17, 2015, 09:46 PM |
| Zane Lee | SVP and Chief Medical Officer | Sep 15, 2015 | Option Exercise | $5.59 | 14,000 | 78,260 | 42,744 | Sep 17, 2015, 09:45 PM |
| Zane Lee | SVP and Chief Medical Officer | Sep 15, 2015 | Sale | $139.84 | 14,000 | 1,957,702 | 41,244 | Sep 17, 2015, 09:45 PM |
| BERNS PAUL L | President and CEO | Aug 13, 2015 | Option Exercise | $5.11 | 20,000 | 102,200 | 274,760 | Aug 17, 2015, 08:00 PM |
| BERNS PAUL L | President and CEO | Aug 13, 2015 | Sale | $138.69 | 20,000 | 2,773,879 | 273,105 | Aug 17, 2015, 08:00 PM |
| Zane Lee | SVP and Chief Medical Officer | Jun 15, 2015 | Option Exercise | $6.44 | 12,000 | 77,269 | 35,817 | Jun 17, 2015, 06:56 PM |
| Zane Lee | SVP and Chief Medical Officer | Jun 15, 2015 | Sale | $69.05 | 12,000 | 828,590 | 28,156 | Jun 17, 2015, 06:56 PM |
| Maples Kirk R | SVP, Program Management | Jun 01, 2015 | Sale | $70.31 | 600 | 42,188 | 7,320 | Jun 02, 2015, 08:00 PM |
| Plattner Jacob j | Senior VP, Research | May 15, 2015 | Sale | $63.73 | 8,920 | 568,472 | 17,840 | May 15, 2015, 08:18 PM |
| Maples Kirk R | SVP, Program Management | May 12, 2015 | Option Exercise | $6.92 | 6,060 | 41,935 | 13,880 | May 14, 2015, 09:12 PM |
| Maples Kirk R | SVP, Program Management | May 12, 2015 | Sale | $61.07 | 6,060 | 370,087 | 8,980 | May 14, 2015, 09:12 PM |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | May 13, 2015 | Option Exercise | $11.80 | 41,768 | 492,996 | 28,686 | May 14, 2015, 09:11 PM |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | May 12, 2015 | Option Exercise | $6.96 | 14,174 | 98,640 | 26,915 | May 14, 2015, 09:11 PM |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | May 14, 2015 | Sale | $63.76 | 6,000 | 382,551 | 7,020 | May 14, 2015, 09:11 PM |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | May 13, 2015 | Sale | $62.80 | 41,768 | 2,623,221 | 13,020 | May 14, 2015, 09:11 PM |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | May 12, 2015 | Sale | $62.05 | 14,174 | 879,551 | 13,020 | May 14, 2015, 09:11 PM |
| Maples Kirk R | SVP, Program Management | May 01, 2015 | Sale | $53.95 | 600 | 32,370 | 8,320 | May 01, 2015, 07:25 PM |
| Sullivan Ryan T | Sr. VP and General Counsel | Apr 29, 2015 | Sale | $53.61 | 3,125 | 167,531 | 27,740 | May 01, 2015, 05:01 PM |
| BERNS PAUL L | President and CEO | Apr 24, 2015 | Sale | $65.28 | 25,000 | 1,631,977 | 295,927 | Apr 28, 2015, 08:37 PM |
| BERNS PAUL L | President and CEO | Apr 27, 2015 | Sale | $61.99 | 25,000 | 1,549,844 | 271,136 | Apr 28, 2015, 08:37 PM |
| Plattner Jacob j | Senior VP, Research | Apr 15, 2015 | Sale | $62.81 | 8,920 | 560,265 | 26,760 | Apr 17, 2015, 04:06 PM |
| Maples Kirk R | SVP, Program Management | Apr 01, 2015 | Sale | $57.01 | 600 | 34,209 | 8,420 | Apr 03, 2015, 04:07 PM |
| Parker Geoffrey M. | Executive Vice President & CFO | Mar 23, 2015 | Buy | $52.43 | 3,000 | 157,304 | 173,000 | Mar 23, 2015, 06:55 PM |
| BERNS PAUL L | President and CEO | Mar 19, 2015 | Sale | $56.07 | 37,500 | 2,102,644 | 308,760 | Mar 23, 2015, 06:53 PM |
| Plattner Jacob j | Senior VP, Research | Mar 16, 2015 | Sale | $55.60 | 8,920 | 495,952 | 35,680 | Mar 18, 2015, 07:35 PM |
| Zane Lee | SVP and Chief Medical Officer | Mar 16, 2015 | Option Exercise | $6.92 | 12,000 | 83,040 | 40,156 | Mar 18, 2015, 07:33 PM |
| Zane Lee | SVP and Chief Medical Officer | Mar 16, 2015 | Sale | $56.44 | 12,000 | 677,225 | 32,256 | Mar 18, 2015, 07:33 PM |
| Chanda Sanjay | SVP, Drug Development | Mar 04, 2015 | Option Exercise | $7.25 | 5,000 | 36,264 | 34,039 | Mar 04, 2015, 07:22 PM |
| Chanda Sanjay | SVP, Drug Development | Mar 04, 2015 | Sale | $45.00 | 5,000 | 225,000 | 29,087 | Mar 04, 2015, 07:22 PM |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | Mar 03, 2015 | Sale | $43.88 | 9,000 | 394,937 | 71,757 | Mar 04, 2015, 07:20 PM |
| Plattner Jacob j | Senior VP, Research | Mar 02, 2015 | Sale | $44.02 | 6,875 | 302,656 | 45,000 | Mar 04, 2015, 07:18 PM |
| Maples Kirk R | SVP, Program Management | Mar 02, 2015 | Sale | $43.95 | 600 | 26,369 | 9,020 | Mar 04, 2015, 07:17 PM |
| Maples Kirk R | SVP, Program Management | Feb 02, 2015 | Sale | $37.41 | 600 | 22,448 | 4,600 | Feb 04, 2015, 04:10 PM |
| Plattner Jacob j | Senior VP, Research | Feb 02, 2015 | Sale | $37.35 | 6,875 | 256,781 | 51,475 | Feb 04, 2015, 04:08 PM |
| Plattner Jacob j | Senior VP, Research | Jan 02, 2015 | Sale | $32.09 | 6,875 | 220,619 | 58,350 | Jan 06, 2015, 04:27 PM |
| Maples Kirk R | SVP, Program Management | Jan 02, 2015 | Sale | $31.96 | 600 | 19,174 | 4,200 | Jan 06, 2015, 04:25 PM |
| Zane Lee | SVP and Chief Medical Officer | Dec 29, 2014 | Option Exercise | $6.74 | 14,291 | 96,297 | 21,291 | Dec 31, 2014, 04:17 PM |
| BERNS PAUL L | President and CEO | Dec 26, 2014 | Sale | $30.82 | 25,000 | 770,505 | 325,000 | Dec 29, 2014, 04:07 PM |
| Chanda Sanjay | SVP, Drug Development | Dec 19, 2014 | Option Exercise | $6.08 | 19,073 | 115,943 | 23,068 | Dec 22, 2014, 08:04 PM |
| Shapiro Lucy | Director | Dec 10, 2014 | Option Exercise | $6.95 | 89,021 | 618,971 | 66,248 | Dec 12, 2014, 06:49 PM |
| Shapiro Lucy | Director | Dec 10, 2014 | Sale | $35.79 | 89,021 | 3,185,741 | 36,248 | Dec 12, 2014, 06:49 PM |
| Shapiro Lucy | Director | Dec 12, 2014 | Sale | $34.48 | 5,447 | 187,813 | 0 | Dec 12, 2014, 06:49 PM |
| Shapiro Lucy | Director | Dec 12, 2014 | Sale | $34.45 | 44,384 | 1,528,873 | 28,000 | Dec 12, 2014, 06:49 PM |
| Shapiro Lucy | Director | Dec 11, 2014 | Sale | $34.92 | 120,032 | 4,191,878 | 72,384 | Dec 12, 2014, 06:49 PM |
| Shapiro Lucy | Director | Dec 11, 2014 | Sale | $34.91 | 30,801 | 1,075,183 | 5,447 | Dec 12, 2014, 06:49 PM |
| Zane Lee | SVP and Chief Medical Officer | Dec 11, 2014 | Option Exercise | $5.00 | 100 | 500 | 7,100 | Dec 12, 2014, 06:47 PM |
| Zane Lee | SVP and Chief Medical Officer | Dec 10, 2014 | Option Exercise | $5.00 | 4,800 | 24,000 | 11,800 | Dec 12, 2014, 06:47 PM |
| Zane Lee | SVP and Chief Medical Officer | Dec 11, 2014 | Sale | $36.00 | 100 | 3,600 | 7,000 | Dec 12, 2014, 06:47 PM |
| Zane Lee | SVP and Chief Medical Officer | Dec 10, 2014 | Sale | $36.09 | 4,800 | 173,251 | 7,000 | Dec 12, 2014, 06:47 PM |
| Maples Kirk R | SVP, Program Management | Dec 09, 2014 | Option Exercise | $6.03 | 60,000 | 361,862 | 44,904 | Dec 10, 2014, 07:08 PM |
| Maples Kirk R | SVP, Program Management | Dec 09, 2014 | Sale | $36.52 | 60,000 | 2,191,404 | 4,800 | Dec 10, 2014, 07:08 PM |
| Plattner Jacob j | Senior VP, Research | Dec 01, 2014 | Sale | $33.34 | 6,875 | 229,237 | 66,125 | Dec 03, 2014, 07:09 PM |
| Maples Kirk R | SVP, Program Management | Dec 01, 2014 | Sale | $33.38 | 600 | 20,025 | 4,900 | Dec 03, 2014, 07:08 PM |
| Chanda Sanjay | SVP, Drug Development | Nov 26, 2014 | Option Exercise | $7.25 | 5,000 | 36,250 | 8,995 | Dec 01, 2014, 07:50 PM |
| Chanda Sanjay | SVP, Drug Development | Nov 26, 2014 | Sale | $35.00 | 5,000 | 175,000 | 3,995 | Dec 01, 2014, 07:50 PM |
| Maples Kirk R | SVP, Program Management | Nov 03, 2014 | Sale | $29.09 | 600 | 17,457 | 5,400 | Nov 04, 2014, 07:09 PM |
| Plattner Jacob j | Senior VP, Research | Nov 03, 2014 | Sale | $29.32 | 6,875 | 201,563 | 72,100 | Nov 04, 2014, 07:06 PM |
| Maples Kirk R | SVP, Program Management | Oct 01, 2014 | Sale | $23.85 | 600 | 14,312 | 6,000 | Oct 02, 2014, 04:33 PM |
| Plattner Jacob j | Senior VP, Research | Oct 01, 2014 | Sale | $24.47 | 6,875 | 168,231 | 78,975 | Oct 02, 2014, 04:31 PM |
| Hove Anders D | Director | Sep 26, 2014 | Sale | $25.00 | 20,000 | 500,000 | 2,725,535 | Sep 30, 2014, 02:13 PM |
| Hove Anders D | Director | Sep 19, 2014 | Sale | $24.87 | 738,500 | 18,366,496 | 2,745,535 | Sep 22, 2014, 05:19 PM |
| Hove Anders D | Director | Sep 18, 2014 | Sale | $24.87 | 1,500 | 37,305 | 3,484,035 | Sep 22, 2014, 05:19 PM |
| Hove Anders D | Director | Sep 16, 2014 | Sale | $24.99 | 75,000 | 1,874,250 | 3,485,535 | Sep 16, 2014, 05:55 PM |
| Hove Anders D | Director | Sep 12, 2014 | Sale | $24.98 | 15,000 | 374,700 | 3,560,535 | Sep 16, 2014, 05:55 PM |
| Chanda Sanjay | SVP, Drug Development | Sep 10, 2014 | Option Exercise | $6.14 | 10,000 | 61,356 | 9,042 | Sep 12, 2014, 04:08 PM |
| Chanda Sanjay | SVP, Drug Development | Sep 10, 2014 | Sale | $24.25 | 10,000 | 242,500 | 3,995 | Sep 12, 2014, 04:08 PM |
| Parker Geoffrey M. | Executive Vice President & CFO | Sep 08, 2014 | Buy | $22.05 | 1,229 | 27,095 | 170,000 | Sep 08, 2014, 04:31 PM |
| Parker Geoffrey M. | Executive Vice President & CFO | Sep 05, 2014 | Buy | $21.77 | 5,361 | 116,712 | 168,771 | Sep 08, 2014, 04:31 PM |
| Maples Kirk R | SVP, Program Management | Sep 02, 2014 | Option Exercise | $6.56 | 32,185 | 211,156 | 30,619 | Sep 04, 2014, 05:45 PM |
| Maples Kirk R | SVP, Program Management | Sep 02, 2014 | Sale | $23.30 | 33,879 | 789,335 | 8,294 | Sep 04, 2014, 05:45 PM |
| Plattner Jacob j | Senior VP, Research | Sep 02, 2014 | Sale | $23.34 | 6,875 | 160,444 | 85,850 | Sep 04, 2014, 05:43 PM |
| LESCHLY MARK | Director | Aug 27, 2014 | Sale | $22.50 | 13,067 | 294,008 | 0 | Aug 29, 2014, 04:05 PM |
| Plattner Jacob j | Senior VP, Research | Aug 13, 2014 | Sale | $20.00 | 6,875 | 137,500 | 92,725 | Aug 15, 2014, 04:31 PM |
| Maples Kirk R | SVP, Program Management | Aug 13, 2014 | Option Exercise | $6.95 | 11,253 | 78,201 | 11,886 | Aug 15, 2014, 04:27 PM |
| Maples Kirk R | SVP, Program Management | Aug 13, 2014 | Sale | $19.96 | 3,959 | 79,012 | 8,294 | Aug 15, 2014, 04:27 PM |
| Maples Kirk R | SVP, Program Management | Jun 04, 2014 | Sale | $14.70 | 1,620 | 23,811 | 620 | Jun 06, 2014, 04:34 PM |
| Maples Kirk R | SVP, Program Management | May 20, 2014 | Sale | $14.15 | 1,500 | 21,231 | 1,620 | May 22, 2014, 04:45 PM |
| Sullivan Ryan T | Sr. VP and General Counsel | Apr 28, 2014 | Option Exercise | $15.30 | 25,000 | 382,500 | 25,000 | Apr 29, 2014, 08:22 PM |
| Maples Kirk R | SVP, Program Management | Apr 21, 2014 | Sale | $15.60 | 1,500 | 23,397 | 3,120 | Apr 22, 2014, 07:01 PM |
| BERNS PAUL L | President and CEO | Mar 21, 2014 | Option Exercise | $21.21 | 350,000 | 7,423,500 | 350,000 | Mar 25, 2014, 05:18 PM |
| Shapiro Lucy | Director | Mar 21, 2014 | Sale | $21.14 | 80,000 | 1,691,392 | 192,416 | Mar 25, 2014, 04:59 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Mar 24, 2014 | Buy | $20.11 | 5,000 | 100,533 | 163,410 | Mar 24, 2014, 06:41 PM |
| Maples Kirk R | SVP, Program Management | Mar 20, 2014 | Sale | $22.39 | 3,000 | 67,164 | 5,239 | Mar 24, 2014, 06:35 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Mar 18, 2014 | Buy | $22.60 | 2,410 | 54,469 | 158,410 | Mar 19, 2014, 07:53 PM |
| PERRY DAVID P | President and CEO | Mar 05, 2014 | Sale | $20.24 | 7,500 | 151,814 | 361,306 | Mar 06, 2014, 06:16 PM |
| PERRY DAVID P | President and CEO | Mar 04, 2014 | Sale | $20.22 | 57,500 | 1,162,583 | 418,806 | Mar 06, 2014, 06:16 PM |
| Maples Kirk R | SVP, Program Management | Feb 20, 2014 | Sale | $19.33 | 3,000 | 57,977 | 7,620 | Feb 21, 2014, 06:34 PM |
| PERRY DAVID P | President and CEO | Feb 04, 2014 | Sale | $17.29 | 7,500 | 129,704 | 433,806 | Feb 05, 2014, 07:30 PM |
| PERRY DAVID P | President and CEO | Feb 05, 2014 | Sale | $16.71 | 7,500 | 125,303 | 426,306 | Feb 05, 2014, 07:30 PM |
| Plattner Jacob j | Senior VP, Research | Jan 27, 2014 | Option Exercise | $0.60 | 44,600 | 26,760 | 99,600 | Jan 28, 2014, 06:42 PM |
| Maples Kirk R | SVP, Program Management | Jan 21, 2014 | Sale | $20.27 | 3,000 | 60,824 | 9,620 | Jan 22, 2014, 04:04 PM |
| PERRY DAVID P | President and CEO | Jan 09, 2014 | Sale | $16.49 | 7,500 | 123,652 | 441,306 | Jan 09, 2014, 06:27 PM |
| PERRY DAVID P | President and CEO | Jan 08, 2014 | Sale | $16.30 | 57,500 | 937,455 | 498,806 | Jan 09, 2014, 06:27 PM |
| Maples Kirk R | SVP, Program Management | Dec 20, 2013 | Sale | $16.73 | 3,000 | 50,179 | 12,620 | Dec 24, 2013, 03:03 PM |
| PERRY DAVID P | President and CEO | Dec 09, 2013 | Option Exercise | $0.60 | 285,480 | 171,288 | 516,634 | Dec 09, 2013, 07:55 PM |
| PERRY DAVID P | President and CEO | Dec 09, 2013 | Sale | $16.72 | 10,328 | 172,717 | 506,306 | Dec 09, 2013, 07:55 PM |
| PERRY DAVID P | President and CEO | Dec 06, 2013 | Sale | $16.85 | 15,000 | 252,699 | 240,954 | Dec 09, 2013, 07:55 PM |
| PERRY DAVID P | President and CEO | Dec 05, 2013 | Sale | $15.28 | 15,000 | 229,171 | 249,054 | Dec 09, 2013, 07:55 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Nov 26, 2013 | Buy | $13.40 | 10,000 | 133,950 | 156,000 | Nov 27, 2013, 04:28 PM |
| Maples Kirk R | SVP, Program Management | Nov 25, 2013 | Option Exercise | $12.78 | 19,162 | 244,896 | 15,620 | Nov 26, 2013, 04:35 PM |
| Maples Kirk R | SVP, Program Management | Nov 25, 2013 | Option Exercise | $6.98 | 34,782 | 242,713 | 24,767 | Nov 26, 2013, 04:35 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Nov 25, 2013 | Buy | $12.85 | 10,000 | 128,475 | 146,000 | Nov 26, 2013, 04:32 PM |
| VENROCK ASSOCIATES IV L P | 10% Owner | Nov 15, 2013 | Sale | $14.06 | 150,000 | 2,109,000 | 3,575,535 | Nov 19, 2013, 05:20 PM |
| Hove Anders D | Director | Nov 15, 2013 | Sale | $14.06 | 150,000 | 2,109,000 | 3,575,535 | Nov 19, 2013, 05:14 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Oct 04, 2013 | Option Exercise | $5.00 | 80,000 | 400,000 | 85,000 | Oct 04, 2013, 08:28 PM |
| Maples Kirk R | SVP, Program Management | Aug 14, 2013 | Sale | $9.71 | 1,052 | 10,216 | 0 | Aug 14, 2013, 09:02 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Aug 13, 2013 | Buy | $8.34 | 50,000 | 417,205 | 136,000 | Aug 13, 2013, 09:06 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Jun 19, 2013 | Buy | $5.20 | 23,046 | 119,948 | 86,000 | Jun 19, 2013, 06:43 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Jun 18, 2013 | Buy | $5.22 | 10,000 | 52,180 | 10,000 | Jun 18, 2013, 08:44 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Jun 18, 2013 | Buy | $5.22 | 10,000 | 52,193 | 62,954 | Jun 18, 2013, 08:44 PM |
| Maples Kirk R | SVP, Program Management | Jun 14, 2013 | Sale | $5.39 | 5,600 | 30,190 | 1,652 | Jun 14, 2013, 07:45 PM |
| Shapiro Lucy | Director | Apr 19, 2013 | Sale | $8.02 | 25,000 | 200,400 | 287,416 | Apr 19, 2013, 09:00 PM |
| Shapiro Lucy | Director | Mar 22, 2013 | Sale | $6.91 | 20,000 | 138,200 | 307,416 | Mar 22, 2013, 07:32 PM |
| Plattner Jacob j | Senior VP, Research | Dec 06, 2012 | Option Exercise | $0.60 | 20,000 | 12,000 | 55,000 | Dec 07, 2012, 04:41 PM |
| Maples Kirk R | SVP, Program Management | Nov 26, 2012 | Sale | $5.22 | 3,000 | 15,666 | 4,652 | Nov 27, 2012, 05:06 PM |
| Maples Kirk R | SVP, Program Management | Nov 01, 2012 | Sale | $5.81 | 3,000 | 17,430 | 7,652 | Nov 02, 2012, 04:41 PM |
| Shapiro Lucy | Director | Oct 05, 2012 | Sale | $6.66 | 15,000 | 99,899 | 317,416 | Oct 05, 2012, 05:35 PM |
| Shapiro Lucy | Director | Oct 03, 2012 | Sale | $6.68 | 15,000 | 100,275 | 332,416 | Oct 05, 2012, 05:35 PM |
| Shapiro Lucy | Director | Oct 01, 2012 | Sale | $6.54 | 14,400 | 94,126 | 347,416 | Oct 01, 2012, 07:53 PM |
| Shapiro Lucy | Director | Sep 28, 2012 | Sale | $6.65 | 5,600 | 37,224 | 361,816 | Oct 01, 2012, 07:53 PM |
| Shapiro Lucy | Director | Sep 26, 2012 | Sale | $6.58 | 10,000 | 65,800 | 367,416 | Sep 28, 2012, 02:20 PM |
| Maples Kirk R | SVP, Program Management | Sep 24, 2012 | Sale | $6.55 | 3,000 | 19,664 | 10,652 | Sep 25, 2012, 02:43 PM |
| Maples Kirk R | SVP, Program Management | Jul 30, 2012 | Sale | $6.03 | 3,000 | 18,087 | 15,652 | Sep 25, 2012, 02:39 PM |
| Shapiro Lucy | Director | Sep 24, 2012 | Sale | $6.35 | 10,000 | 63,540 | 377,416 | Sep 24, 2012, 05:25 PM |
| Shapiro Lucy | Director | Sep 21, 2012 | Sale | $6.30 | 10,000 | 62,960 | 387,416 | Sep 24, 2012, 05:25 PM |
| VENROCK ASSOCIATES V LP | 10% Owner | Sep 20, 2012 | Sale | $6.30 | 19,273 | 121,457 | 3,725,535 | Sep 24, 2012, 04:15 PM |
| VENROCK ASSOCIATES IV L P | 10% Owner | Sep 20, 2012 | Sale | $6.30 | 19,273 | 121,457 | 3,725,535 | Sep 24, 2012, 04:12 PM |
| Hove Anders D | Director | Sep 20, 2012 | Sale | $6.30 | 19,273 | 121,457 | 3,725,535 | Sep 24, 2012, 04:06 PM |
| VENROCK ASSOCIATES V LP | 10% Owner | Sep 14, 2012 | Sale | $6.51 | 35,000 | 227,804 | 3,744,808 | Sep 18, 2012, 02:42 PM |
| VENROCK ASSOCIATES IV L P | 10% Owner | Sep 14, 2012 | Sale | $6.51 | 35,000 | 227,804 | 3,744,808 | Sep 18, 2012, 02:41 PM |
| Hove Anders D | Director | Sep 14, 2012 | Sale | $6.51 | 35,000 | 227,804 | 3,744,808 | Sep 18, 2012, 02:40 PM |
| VENROCK ASSOCIATES V LP | 10% Owner | Sep 11, 2012 | Sale | $6.64 | 10,177 | 67,603 | 3,794,808 | Sep 13, 2012, 06:24 PM |
| VENROCK ASSOCIATES V LP | 10% Owner | Sep 13, 2012 | Sale | $6.56 | 15,000 | 98,330 | 3,779,808 | Sep 13, 2012, 06:24 PM |
| VENROCK ASSOCIATES IV L P | 10% Owner | Sep 13, 2012 | Sale | $6.56 | 15,000 | 98,330 | 3,779,808 | Sep 13, 2012, 06:23 PM |
| VENROCK ASSOCIATES IV L P | 10% Owner | Sep 11, 2012 | Sale | $6.64 | 10,177 | 67,603 | 3,794,808 | Sep 13, 2012, 06:23 PM |
| Hove Anders D | Director | Sep 13, 2012 | Sale | $6.56 | 15,000 | 98,330 | 3,779,808 | Sep 13, 2012, 06:22 PM |
| Hove Anders D | Director | Sep 11, 2012 | Sale | $6.64 | 10,177 | 67,603 | 3,794,808 | Sep 13, 2012, 06:22 PM |
| Maples Kirk R | SVP, Program Management | Aug 27, 2012 | Sale | $6.17 | 3,000 | 18,497 | 13,652 | Aug 28, 2012, 02:34 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Aug 22, 2012 | Buy | $6.19 | 5,000 | 30,956 | 55,954 | Aug 24, 2012, 12:07 PM |
| Maples Kirk R | SVP, Program Management | Jul 30, 2012 | Sale | $6.03 | 3,000 | 18,087 | 15,652 | Aug 01, 2012, 03:09 PM |
| Maples Kirk R | SVP, Program Management | Jun 25, 2012 | Sale | $5.44 | 3,000 | 16,320 | 18,652 | Jun 27, 2012, 03:08 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Jun 05, 2012 | Buy | $4.93 | 4,314 | 21,259 | 49,954 | Jun 05, 2012, 07:21 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Jun 04, 2012 | Buy | $4.68 | 3,640 | 17,035 | 45,640 | Jun 05, 2012, 07:21 PM |
| Maples Kirk R | SVP, Program Management | May 29, 2012 | Sale | $5.34 | 3,000 | 16,025 | 21,652 | May 30, 2012, 03:29 PM |
| Maples Kirk R | SVP, Program Management | Apr 23, 2012 | Sale | $5.46 | 3,000 | 16,388 | 24,652 | Apr 24, 2012, 03:39 PM |
| Maples Kirk R | SVP, Program Management | Mar 26, 2012 | Sale | $6.45 | 3,000 | 19,342 | 27,652 | Mar 27, 2012, 02:49 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Mar 20, 2012 | Buy | $6.08 | 9,400 | 57,196 | 42,000 | Mar 20, 2012, 06:13 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | Mar 19, 2012 | Buy | $6.03 | 600 | 3,618 | 32,600 | Mar 20, 2012, 06:13 PM |
| Maples Kirk R | SVP, Program Management | Feb 27, 2012 | Sale | $5.90 | 3,000 | 17,694 | 30,652 | Feb 28, 2012, 05:21 PM |
| Maples Kirk R | SVP, Program Management | Jan 30, 2012 | Sale | $7.11 | 3,000 | 21,344 | 31,652 | Jan 31, 2012, 02:01 PM |
| Maples Kirk R | SVP, Program Management | Jan 10, 2012 | Sale | $5.48 | 3,000 | 16,451 | 34,652 | Jan 11, 2012, 05:53 PM |
| Maples Kirk R | S.V.P., Program Management | Dec 30, 2011 | Sale | $6.14 | 10,000 | 61,450 | 37,652 | Jan 09, 2012, 02:37 PM |
| Maples Kirk R | SVP Program Management | Dec 29, 2011 | Sale | $6.14 | 6,000 | 36,862 | 47,652 | Jan 03, 2012, 04:31 PM |
| Maples Kirk R | S.V.P., Program Management | Nov 28, 2011 | Sale | $4.91 | 4,000 | 19,633 | 53,652 | Nov 29, 2011, 11:09 AM |
| Maples Kirk R | SVP Program Management | Oct 31, 2011 | Sale | $6.65 | 4,000 | 26,590 | 57,652 | Nov 01, 2011, 02:47 PM |
| Maples Kirk R | S.V.P., Program Management | Sep 26, 2011 | Sale | $5.22 | 4,000 | 20,892 | 61,652 | Sep 27, 2011, 11:31 AM |
| Maples Kirk R | S.V.P., Program Management | Aug 29, 2011 | Sale | $4.82 | 4,000 | 19,266 | 65,652 | Aug 30, 2011, 04:34 PM |
| Maples Kirk R | SVP, Program Management | Jul 25, 2011 | Sale | $6.16 | 4,000 | 24,656 | 69,652 | Jul 26, 2011, 05:19 PM |
| Maples Kirk R | SVP, Program Management | Jun 27, 2011 | Sale | $6.40 | 4,000 | 25,596 | 73,652 | Jun 28, 2011, 02:13 PM |
| Plattner Jacob j | Senior VP, Research | Jun 03, 2011 | Option Exercise | $0.60 | 15,000 | 9,000 | 15,000 | Jun 07, 2011, 05:23 PM |
| Maples Kirk R | SVP, Program Management | Jun 06, 2011 | Sale | $6.05 | 5,000 | 30,273 | 77,652 | Jun 07, 2011, 02:52 PM |
| Maples Kirk R | SVP, Program Management | Jun 01, 2011 | Sale | $6.00 | 5,000 | 30,001 | 82,652 | Jun 03, 2011, 04:26 PM |
| Maples Kirk R | SVP, Program Management | May 25, 2011 | Option Exercise | $0.60 | 40,000 | 24,000 | 91,428 | May 26, 2011, 04:24 PM |
| Maples Kirk R | SVP, Program Management | May 24, 2011 | Option Exercise | $0.49 | 56,020 | 27,357 | 56,020 | May 26, 2011, 04:24 PM |
| Maples Kirk R | SVP, Program Management | May 24, 2011 | Sale | $6.00 | 4,592 | 27,552 | 51 | May 26, 2011, 04:24 PM |
| Maples Kirk R | SVP, Program Management | May 25, 2011 | Sale | $6.44 | 3,776 | 24,301 | 90,898 | May 26, 2011, 04:24 PM |
| Parker Geoffrey M. | Sr. V.P. & CFO | May 24, 2011 | Buy | $5.92 | 5,000 | 29,600 | 30,000 | May 24, 2011, 03:44 PM |
| Parker Geoffrey M. | Sr. V.P. & CFO | May 23, 2011 | Buy | $5.99 | 5,000 | 29,932 | 25,000 | May 24, 2011, 03:44 PM |
| Parker Geoffrey M. | Senior Vice President and CFO | May 10, 2011 | Buy | $6.17 | 20,000 | 123,374 | 20,000 | May 11, 2011, 05:06 PM |
| VENROCK ASSOCIATES IV L P | 10% Owner | Nov 30, 2010 | Buy | $5.00 | 600,000 | 3,000,000 | 2,625,535 | Dec 02, 2010, 03:10 PM |
| Hove Anders D | Director | Nov 30, 2010 | Option Exercise | $5.00 | 2,000,000 | 10,000,000 | 4,625,535 | Dec 02, 2010, 03:09 PM |
| Hove Anders D | Director | Nov 30, 2010 | Buy | $5.00 | 600,000 | 3,000,000 | 2,625,535 | Dec 02, 2010, 03:09 PM |
| RHO VENTURES IV QP LP | 10% Owner | Nov 30, 2010 | Buy | $5.00 | 2,400,000 | 12,000,000 | 5,621,423 | Dec 02, 2010, 12:01 PM |
| Aberdare Ventures II, L.P. | 10% Owner | Nov 30, 2010 | Buy | $5.00 | 300,000 | 1,500,000 | 1,751,936 | Dec 01, 2010, 06:08 PM |
| LESCHLY MARK | Director | Nov 30, 2010 | Buy | $5.00 | 2,400,000 | 12,000,000 | 5,621,423 | Dec 01, 2010, 06:06 PM |
| KLINGENSTEIN PAUL H | Director | Nov 30, 2010 | Buy | $5.00 | 300,000 | 1,500,000 | 1,751,936 | Dec 01, 2010, 06:05 PM |
| GLAXOSMITHKLINE PLC | 10% Owner | Nov 24, 2010 | Buy | $5.00 | 1,000,000 | 5,000,000 | 2,771,374 | Nov 24, 2010, 12:21 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Hove Anders D | Director | 06/24/2016 | 3,363,186 |
| Shapiro Lucy | Director | 06/24/2016 | 78,805 |
| RIEFLIN WILLIAM JL | Director | 06/24/2016 | 84,660 |
| RIEFLIN WILLIAM JL | Director | 06/24/2016 | 8,833,250 |
| LESCHLY MARK | Director | 06/24/2016 | 78,805 |
| Leonard Keith R | Director | 06/24/2016 | 78,805 |
| WIERENGA WENDALL | Director | 06/24/2016 | 78,805 |
| Zane Lee | SVP and Chief Medical Officer | 06/24/2016 | 4,386,255 |
| Bell Graeme | Executive VP and CFO | 06/24/2016 | 1,040,934 |
| BERNS PAUL L | President and CEO | 06/24/2016 | 22,957,617 |
| Sullivan Ryan T | EVP and General Counsel | 06/24/2016 | 2,990,601 |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 06/24/2016 | 6,846,761 |
| Bell Graeme | Executive VP and CFO | 06/01/2016 | 74,559 |
| Leonard Keith R | Director | 05/23/2016 | 127,980 |
| Leonard Keith R | Director | 05/23/2016 | 897,300 |
| Hove Anders D | Director | 05/16/2016 | 35,241,707 |
| Sullivan Ryan T | EVP and General Counsel | 04/29/2016 | 207,281 |
| Hove Anders D | Director | 04/14/2016 | 7,999,939 |
| Hove Anders D | Director | 04/08/2016 | 299,513 |
| Hove Anders D | Director | 04/07/2016 | 16,004,432 |
| RIEFLIN WILLIAM JL | Director | 03/31/2016 | 741,080 |
| BERNS PAUL L | President and CEO | 03/22/2016 | 2,261,616 |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 03/02/2016 | 574,753 |
| Zane Lee | SVP and Chief Medical Officer | 01/22/2016 | 89,090 |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 01/19/2016 | 399,200 |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 01/19/2016 | 1,908,204 |
| Zane Lee | SVP and Chief Medical Officer | 01/15/2016 | 131,310 |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 01/04/2016 | 96,002 |
| Sullivan Ryan T | Sr. VP and General Counsel | 01/04/2016 | 81,935 |
| BERNS PAUL L | President and CEO | 01/04/2016 | 284,581 |
| Zane Lee | SVP and Chief Medical Officer | 12/15/2015 | 78,260 |
| Zane Lee | SVP and Chief Medical Officer | 12/15/2015 | 1,584,350 |
| Hove Anders D | Director | 12/15/2015 | 100,125,000 |
| BERNS PAUL L | President and CEO | 12/11/2015 | 200,060 |
| BERNS PAUL L | President and CEO | 12/11/2015 | 2,345,245 |
| Hove Anders D | Director | 12/11/2015 | 4,694,400 |
| Sullivan Ryan T | Sr. VP and General Counsel | 12/10/2015 | 153,000 |
| Sullivan Ryan T | Sr. VP and General Counsel | 12/10/2015 | 1,104,108 |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 12/09/2015 | 399,200 |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 12/09/2015 | 2,158,097 |
| Hove Anders D | Director | 11/10/2015 | 10,390,562 |
| BERNS PAUL L | President and CEO | 09/15/2015 | 103,640 |
| BERNS PAUL L | President and CEO | 09/15/2015 | 2,796,525 |
| Zane Lee | SVP and Chief Medical Officer | 09/15/2015 | 78,260 |
| Zane Lee | SVP and Chief Medical Officer | 09/15/2015 | 1,957,702 |
| BERNS PAUL L | President and CEO | 08/13/2015 | 102,200 |
| BERNS PAUL L | President and CEO | 08/13/2015 | 2,773,879 |
| Zane Lee | SVP and Chief Medical Officer | 06/15/2015 | 77,269 |
| Zane Lee | SVP and Chief Medical Officer | 06/15/2015 | 828,590 |
| Maples Kirk R | SVP, Program Management | 06/01/2015 | 42,188 |
| Plattner Jacob j | Senior VP, Research | 05/15/2015 | 568,472 |
| Maples Kirk R | SVP, Program Management | 05/12/2015 | 41,935 |
| Maples Kirk R | SVP, Program Management | 05/12/2015 | 370,087 |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | 05/13/2015 | 492,996 |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | 05/12/2015 | 98,640 |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | 05/14/2015 | 382,551 |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | 05/13/2015 | 2,623,221 |
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | 05/12/2015 | 879,551 |
| Maples Kirk R | SVP, Program Management | 05/01/2015 | 32,370 |
| Sullivan Ryan T | Sr. VP and General Counsel | 04/29/2015 | 167,531 |
| BERNS PAUL L | President and CEO | 04/24/2015 | 1,631,977 |
| BERNS PAUL L | President and CEO | 04/27/2015 | 1,549,844 |
| Plattner Jacob j | Senior VP, Research | 04/15/2015 | 560,265 |
| Maples Kirk R | SVP, Program Management | 04/01/2015 | 34,209 |
| Parker Geoffrey M. | Executive Vice President & CFO | 03/23/2015 | 157,304 |
| BERNS PAUL L | President and CEO | 03/19/2015 | 2,102,644 |
| Plattner Jacob j | Senior VP, Research | 03/16/2015 | 495,952 |
| Zane Lee | SVP and Chief Medical Officer | 03/16/2015 | 83,040 |
| Zane Lee | SVP and Chief Medical Officer | 03/16/2015 | 677,225 |
| Chanda Sanjay | SVP, Drug Development | 03/04/2015 | 36,264 |
| Chanda Sanjay | SVP, Drug Development | 03/04/2015 | 225,000 |
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 03/03/2015 | 394,937 |
| Plattner Jacob j | Senior VP, Research | 03/02/2015 | 302,656 |
| Maples Kirk R | SVP, Program Management | 03/02/2015 | 26,369 |
| Maples Kirk R | SVP, Program Management | 02/02/2015 | 22,448 |
| Plattner Jacob j | Senior VP, Research | 02/02/2015 | 256,781 |
| Plattner Jacob j | Senior VP, Research | 01/02/2015 | 220,619 |
| Maples Kirk R | SVP, Program Management | 01/02/2015 | 19,174 |
| Zane Lee | SVP and Chief Medical Officer | 12/29/2014 | 96,297 |
| BERNS PAUL L | President and CEO | 12/26/2014 | 770,505 |
| Chanda Sanjay | SVP, Drug Development | 12/19/2014 | 115,943 |
| Shapiro Lucy | Director | 12/10/2014 | 618,971 |
| Shapiro Lucy | Director | 12/10/2014 | 3,185,741 |
| Shapiro Lucy | Director | 12/12/2014 | 187,813 |
| Shapiro Lucy | Director | 12/12/2014 | 1,528,873 |
| Shapiro Lucy | Director | 12/11/2014 | 4,191,878 |
| Shapiro Lucy | Director | 12/11/2014 | 1,075,183 |
| Zane Lee | SVP and Chief Medical Officer | 12/11/2014 | 500 |
| Zane Lee | SVP and Chief Medical Officer | 12/10/2014 | 24,000 |
| Zane Lee | SVP and Chief Medical Officer | 12/11/2014 | 3,600 |
| Zane Lee | SVP and Chief Medical Officer | 12/10/2014 | 173,251 |
| Maples Kirk R | SVP, Program Management | 12/09/2014 | 361,862 |
| Maples Kirk R | SVP, Program Management | 12/09/2014 | 2,191,404 |
| Plattner Jacob j | Senior VP, Research | 12/01/2014 | 229,237 |
| Maples Kirk R | SVP, Program Management | 12/01/2014 | 20,025 |
| Chanda Sanjay | SVP, Drug Development | 11/26/2014 | 36,250 |
| Chanda Sanjay | SVP, Drug Development | 11/26/2014 | 175,000 |
| Maples Kirk R | SVP, Program Management | 11/03/2014 | 17,457 |
| Plattner Jacob j | Senior VP, Research | 11/03/2014 | 201,563 |
| Maples Kirk R | SVP, Program Management | 10/01/2014 | 14,312 |
| Plattner Jacob j | Senior VP, Research | 10/01/2014 | 168,231 |
| Hove Anders D | Director | 09/26/2014 | 500,000 |
| Hove Anders D | Director | 09/19/2014 | 18,366,496 |
| Hove Anders D | Director | 09/18/2014 | 37,305 |
| Hove Anders D | Director | 09/16/2014 | 1,874,250 |
| Hove Anders D | Director | 09/12/2014 | 374,700 |
| Chanda Sanjay | SVP, Drug Development | 09/10/2014 | 61,356 |
| Chanda Sanjay | SVP, Drug Development | 09/10/2014 | 242,500 |
| Parker Geoffrey M. | Executive Vice President & CFO | 09/08/2014 | 27,095 |
| Parker Geoffrey M. | Executive Vice President & CFO | 09/05/2014 | 116,712 |
| Maples Kirk R | SVP, Program Management | 09/02/2014 | 211,156 |
| Maples Kirk R | SVP, Program Management | 09/02/2014 | 789,335 |
| Plattner Jacob j | Senior VP, Research | 09/02/2014 | 160,444 |
| LESCHLY MARK | Director | 08/27/2014 | 294,008 |
| Plattner Jacob j | Senior VP, Research | 08/13/2014 | 137,500 |
| Maples Kirk R | SVP, Program Management | 08/13/2014 | 78,201 |
| Maples Kirk R | SVP, Program Management | 08/13/2014 | 79,012 |
| Maples Kirk R | SVP, Program Management | 06/04/2014 | 23,811 |
| Maples Kirk R | SVP, Program Management | 05/20/2014 | 21,231 |
| Sullivan Ryan T | Sr. VP and General Counsel | 04/28/2014 | 382,500 |
| Maples Kirk R | SVP, Program Management | 04/21/2014 | 23,397 |
| BERNS PAUL L | President and CEO | 03/21/2014 | 7,423,500 |
| Shapiro Lucy | Director | 03/21/2014 | 1,691,392 |
| Parker Geoffrey M. | Senior Vice President and CFO | 03/24/2014 | 100,533 |
| Maples Kirk R | SVP, Program Management | 03/20/2014 | 67,164 |
| Parker Geoffrey M. | Senior Vice President and CFO | 03/18/2014 | 54,469 |
| PERRY DAVID P | President and CEO | 03/05/2014 | 151,814 |
| PERRY DAVID P | President and CEO | 03/04/2014 | 1,162,583 |
| Maples Kirk R | SVP, Program Management | 02/20/2014 | 57,977 |
| PERRY DAVID P | President and CEO | 02/04/2014 | 129,704 |
| PERRY DAVID P | President and CEO | 02/05/2014 | 125,303 |
| Plattner Jacob j | Senior VP, Research | 01/27/2014 | 26,760 |
| Maples Kirk R | SVP, Program Management | 01/21/2014 | 60,824 |
| PERRY DAVID P | President and CEO | 01/09/2014 | 123,652 |
| PERRY DAVID P | President and CEO | 01/08/2014 | 937,455 |
| Maples Kirk R | SVP, Program Management | 12/20/2013 | 50,179 |
| PERRY DAVID P | President and CEO | 12/09/2013 | 171,288 |
| PERRY DAVID P | President and CEO | 12/09/2013 | 172,717 |
| PERRY DAVID P | President and CEO | 12/06/2013 | 252,699 |
| PERRY DAVID P | President and CEO | 12/05/2013 | 229,171 |
| Parker Geoffrey M. | Senior Vice President and CFO | 11/26/2013 | 133,950 |
| Maples Kirk R | SVP, Program Management | 11/25/2013 | 244,896 |
| Maples Kirk R | SVP, Program Management | 11/25/2013 | 242,713 |
| Parker Geoffrey M. | Senior Vice President and CFO | 11/25/2013 | 128,475 |
| VENROCK ASSOCIATES IV L P | 10% Owner | 11/15/2013 | 2,109,000 |
| Hove Anders D | Director | 11/15/2013 | 2,109,000 |
| Parker Geoffrey M. | Senior Vice President and CFO | 10/04/2013 | 400,000 |
| Maples Kirk R | SVP, Program Management | 08/14/2013 | 10,216 |
| Parker Geoffrey M. | Senior Vice President and CFO | 08/13/2013 | 417,205 |
| Parker Geoffrey M. | Senior Vice President and CFO | 06/19/2013 | 119,948 |
| Parker Geoffrey M. | Senior Vice President and CFO | 06/18/2013 | 52,180 |
| Parker Geoffrey M. | Senior Vice President and CFO | 06/18/2013 | 52,193 |
| Maples Kirk R | SVP, Program Management | 06/14/2013 | 30,190 |
| Shapiro Lucy | Director | 04/19/2013 | 200,400 |
| Shapiro Lucy | Director | 03/22/2013 | 138,200 |
| Plattner Jacob j | Senior VP, Research | 12/06/2012 | 12,000 |
| Maples Kirk R | SVP, Program Management | 11/26/2012 | 15,666 |
| Maples Kirk R | SVP, Program Management | 11/01/2012 | 17,430 |
| Shapiro Lucy | Director | 10/05/2012 | 99,899 |
| Shapiro Lucy | Director | 10/03/2012 | 100,275 |
| Shapiro Lucy | Director | 10/01/2012 | 94,126 |
| Shapiro Lucy | Director | 09/28/2012 | 37,224 |
| Shapiro Lucy | Director | 09/26/2012 | 65,800 |
| Maples Kirk R | SVP, Program Management | 09/24/2012 | 19,664 |
| Maples Kirk R | SVP, Program Management | 07/30/2012 | 18,087 |
| Shapiro Lucy | Director | 09/24/2012 | 63,540 |
| Shapiro Lucy | Director | 09/21/2012 | 62,960 |
| VENROCK ASSOCIATES V LP | 10% Owner | 09/20/2012 | 121,457 |
| VENROCK ASSOCIATES IV L P | 10% Owner | 09/20/2012 | 121,457 |
| Hove Anders D | Director | 09/20/2012 | 121,457 |
| VENROCK ASSOCIATES V LP | 10% Owner | 09/14/2012 | 227,804 |
| VENROCK ASSOCIATES IV L P | 10% Owner | 09/14/2012 | 227,804 |
| Hove Anders D | Director | 09/14/2012 | 227,804 |
| VENROCK ASSOCIATES V LP | 10% Owner | 09/11/2012 | 67,603 |
| VENROCK ASSOCIATES V LP | 10% Owner | 09/13/2012 | 98,330 |
| VENROCK ASSOCIATES IV L P | 10% Owner | 09/13/2012 | 98,330 |
| VENROCK ASSOCIATES IV L P | 10% Owner | 09/11/2012 | 67,603 |
| Hove Anders D | Director | 09/13/2012 | 98,330 |
| Hove Anders D | Director | 09/11/2012 | 67,603 |
| Maples Kirk R | SVP, Program Management | 08/27/2012 | 18,497 |
| Parker Geoffrey M. | Senior Vice President and CFO | 08/22/2012 | 30,956 |
| Maples Kirk R | SVP, Program Management | 07/30/2012 | 18,087 |
| Maples Kirk R | SVP, Program Management | 06/25/2012 | 16,320 |
| Parker Geoffrey M. | Senior Vice President and CFO | 06/05/2012 | 21,259 |
| Parker Geoffrey M. | Senior Vice President and CFO | 06/04/2012 | 17,035 |
| Maples Kirk R | SVP, Program Management | 05/29/2012 | 16,025 |
| Maples Kirk R | SVP, Program Management | 04/23/2012 | 16,388 |
| Maples Kirk R | SVP, Program Management | 03/26/2012 | 19,342 |
| Parker Geoffrey M. | Senior Vice President and CFO | 03/20/2012 | 57,196 |
| Parker Geoffrey M. | Senior Vice President and CFO | 03/19/2012 | 3,618 |
| Maples Kirk R | SVP, Program Management | 02/27/2012 | 17,694 |
| Maples Kirk R | SVP, Program Management | 01/30/2012 | 21,344 |
| Maples Kirk R | SVP, Program Management | 01/10/2012 | 16,451 |
| Maples Kirk R | S.V.P., Program Management | 12/30/2011 | 61,450 |
| Maples Kirk R | SVP Program Management | 12/29/2011 | 36,862 |
| Maples Kirk R | S.V.P., Program Management | 11/28/2011 | 19,633 |
| Maples Kirk R | SVP Program Management | 10/31/2011 | 26,590 |
| Maples Kirk R | S.V.P., Program Management | 09/26/2011 | 20,892 |
| Maples Kirk R | S.V.P., Program Management | 08/29/2011 | 19,266 |
| Maples Kirk R | SVP, Program Management | 07/25/2011 | 24,656 |
| Maples Kirk R | SVP, Program Management | 06/27/2011 | 25,596 |
| Plattner Jacob j | Senior VP, Research | 06/03/2011 | 9,000 |
| Maples Kirk R | SVP, Program Management | 06/06/2011 | 30,273 |
| Maples Kirk R | SVP, Program Management | 06/01/2011 | 30,001 |
| Maples Kirk R | SVP, Program Management | 05/25/2011 | 24,000 |
| Maples Kirk R | SVP, Program Management | 05/24/2011 | 27,357 |
| Maples Kirk R | SVP, Program Management | 05/24/2011 | 27,552 |
| Maples Kirk R | SVP, Program Management | 05/25/2011 | 24,301 |
| Parker Geoffrey M. | Sr. V.P. & CFO | 05/24/2011 | 29,600 |
| Parker Geoffrey M. | Sr. V.P. & CFO | 05/23/2011 | 29,932 |
| Parker Geoffrey M. | Senior Vice President and CFO | 05/10/2011 | 123,374 |
| VENROCK ASSOCIATES IV L P | 10% Owner | 11/30/2010 | 3,000,000 |
| Hove Anders D | Director | 11/30/2010 | 10,000,000 |
| Hove Anders D | Director | 11/30/2010 | 3,000,000 |
| RHO VENTURES IV QP LP | 10% Owner | 11/30/2010 | 12,000,000 |
| Aberdare Ventures II, L.P. | 10% Owner | 11/30/2010 | 1,500,000 |
| LESCHLY MARK | Director | 11/30/2010 | 12,000,000 |
| KLINGENSTEIN PAUL H | Director | 11/30/2010 | 1,500,000 |
| GLAXOSMITHKLINE PLC | 10% Owner | 11/24/2010 | 5,000,000 |
Load More Insider Transactions